✦ LIBER ✦

Amplification, mutation and loss of heterozygosity of the EGFR gene in metastatic lung cancer

✍ Scribed by Edmond S.K. Ma; Chris L.P. Wong; Diana Siu; Wai Kong Chan

Publisher: John Wiley and Sons
Year: 2007
Tongue: French
Weight: 390 KB
Volume: 120
Category: Article
ISSN: 0020-7136
DOI: 10.1002/ijc.22506

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognostic value of loss of heterozygosi

Prognostic value of loss of heterozygosity and KRAS2 mutations in lung adenocarcinoma

✍ Laura De Gregorio; Giacomo Manenti; Matteo Incarbone; Silvana Pilotti; Ugo Pasto 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 89 KB

The prognostic values of loss of heterozygosity (LOH) at loci frequently involved in non-small cell lung cancer and of KRAS2 gene mutations were studied in lung adenocarcinoma patients. LOHs were relatively common, ranging from 24% at chromosome 10p to 55% at chromosome 17p13. KRAS2 mutations at cod

BRCA1 gene mutation and loss of heterozy

BRCA1 gene mutation and loss of heterozygosity on chromosome 17q21 in primary prostate cancer

✍ Toyoaki Uchida; Chunxi Wang; Takefumi Sato; Jiangping Gao; Rikiya Takashima; Aki 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 113 KB 👁 1 views

The tumor suppressor gene BRCA1 on chromosome 17q21 has been characterized and shown to be mutated in patients with familial breast and ovarian cancer. Several studies examined the relatives of women with breast cancer and noted an association with ovarian and prostate cancer. This study investigate

Search for loss of heterozygosity and mu

Search for loss of heterozygosity and mutation analysis of KRIT1 gene in CCM patients

✍ Valeria Marini; Loretta Ferrera; Francesca Pigatto; Paola Origone; Cecilia Garrè 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 53 KB 👁 2 views

Genomewide loss of heterozygosity and it

Genomewide loss of heterozygosity and its clinical associations in non small cell lung cancer

✍ Ruo-Chia Tseng; Jer-Wei Chang; Feng-Jen Hsien; Ya-Hui Chang; Chin-Fu Hsiao; Jung 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 462 KB 👁 1 views

## Abstract We extensively allelotyped a panel of 71 microdissected primary surgically resected non small cell lung cancer (NSCLC) tumors to identify chromosomal regions that are likely to contain tumor suppressor genes (TSGs) or associated with clinicopathologic and prognostic effects. Loss of het

Loss of heterozygosity on chromosome 9 a

Loss of heterozygosity on chromosome 9 and p16 (MTS1, CDKN2) gene mutations in esophageal cancers

✍ Françoise Muzeau; Jean François Fléjou; Gilles Thomas; Richard Hamelin 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 131 KB 👁 1 views

Loss of heterozygosity on chromosome 9 has been reported in a variety of human cancers. The cyclin-dependent kinase inhibitor p16 gene, mapped on chromosome 9p21, is presumed to be the tumor-suppressor gene localized in this chromosome. The aim of our study was to determine, in 26 Barrett's adenocar

Loss of heterozygosity and lack of mutat

Loss of heterozygosity and lack of mutations of theXPG/ERCC5 DNA repair gene at 13q33 in prostate cancer

✍ Hyytinen, Eija-Riitta; Frierson, Henry F.; Sipe, Tavis W.; Li, Chang-Ling; Degeo 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 268 KB 👁 2 views

BACKGROUND. Three regions of chromosome 13 were previously identified for having loss of heterozygosity (LOH) in human prostate cancer. One of them, at 13q33, was defined by LOH at markers D13S158 and D13S280. The XPG/ERCC5 gene, a DNA repair gene that when mutated in the germline leads to xeroderma